 lovastatin-treated rodent new model disruption epidermal hyperplasia Recent studies epidermal cholesterol synthesis maintenance permeability barrier importance cholesterol synthesis lovastatin potent inhibitor cholesterol synthesis mouse skin Transepidermal water loss TEWL daily applications Co-application cholesterol expected increase TEWL importance cholesterol development lesion histology lovastatin-treated skin epidermal hyperplasia accelerated DNA synthesis Whereas cholesterol synthesis lovastatin-treated epidermis treatment cholesterol synthesis fatty acid synthesis total free sterol content lovastatin-treated epidermis normal fatty acid content coincident disruption morphologic abnormalities lamellar body structure intercellular contents coincident biochemical abnormalities abnormal barrier function model initial inhibition epidermal sterol synthesis alteration cholesterol fatty acid synthesis imbalance stratum corneum lipid composition abnormal membrane bilayer structure